A phase 1b expansion study of JANX007 monotherapy in NHT- and taxane-experienced mCRPC
Latest Information Update: 15 May 2025
At a glance
- Drugs JANX 007 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
Most Recent Events
- 15 May 2025 New trial record